Adagio Medical
Adagio Medical, Inc. is a Laguna Hills, California medical device company and an operating subsidiary of Adagio Medical Holdings, Inc. (NASDAQ: ADGM). It develops catheter-based cardiac ablation systems built on its proprietary Ultra-Low Temperature Cryoablation (ULTC) platform and an emerging Pulsed Field Cryoablation (PFCA) platform, designed to create large, durable, transmural lesions for the treatment of ventricular tachycardia, atrial fibrillation and atrial flutter. Its CE-marked vCLAS Cryoablation System holds FDA Breakthrough Device Designation and is under U.S. evaluation in the FULCRUM-VT pivotal IDE study. Adagio Medical sells regulated physical devices to hospitals and electrophysiology labs; it publishes no public API, developer portal, SDK or machine-readable contract. It does publish a coordinated product-security vulnerability disclosure policy.
Adagio Medical is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health, Cardiology, and Medical Technology.
Adagio Medical’s developer surface includes support and 7 more developer resources.
Kin Score
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 3
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.